Susan E. Graf, Director at Finch Therapeutics Group, Inc. (FNCH), bought 5,010 shares at $0.27 ($1K) on 2023-06-09, disclosed to the SEC on 2023-06-09.
Open-market purchase of $1k FNCH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.